StonvexLoading…
StonvexStonvexStonvexCore line items from HSY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-29 | Annual 2025 2025-12-31 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|---|
Revenue | $2.67B | $3.10B | $11.69B | $8.60B | $5.42B |
Operating Income | Not available | $640.69M | $1.44B | $996.62M | $562.03M |
Net Income | Not available | $435.11M | $883.26M | $563.24M | $286.92M |
EPS (Diluted) | $1.44 | Not available | Not available | Not available | Not available |
Total Assets | Not available | $13.84B | $13.74B | $13.58B | $13.65B |
Total Liabilities | Not available | $9.11B | $9.10B | $9.01B | $9.13B |
Cash & Equivalents | Not available | $876.98M | $925.86M | $1.16B | $912.35M |
Free Cash Flow OCF − CapEx | Not available | $354.21M | $1.82B | $1.03B | $278.28M |
Shares Outstanding | Not available | Not available | 202.84M | Not available | Not available |